QuilliChew ER Approval History
FDA Approved: Yes (First approved December 7, 2015)
Brand name: QuilliChew ER
Generic name: methylphenidate hydrochloride
Dosage form: Extended Release Chewable Tablets
Company: Pfizer Inc.
Treatment for: ADHD
QuilliChew ER (methylphenidate hydrochloride) is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).
Development History and FDA Approval Process for QuilliChew ER
|Dec 7, 2015||Pfizer Receives FDA Approval for QuilliChew ER (methylphenidate hydrochloride) Extended-Release Chewable Tablets|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.